HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

IFF’s New CEO: Commercial Execution Strategy Will Get Biz Back On Track

Executive Summary

Under CEO Erik Fyrwald, IFF is committed to improving commercial execution across its four businesses after five years of overall underperformance.

You may also be interested in...



IFF Narrows Focus To Fragrance, Health, Food

International Flavors & Fragrances agrees to sell its Pharma Solutions business to plant-based ingredients company Roquette for an enterprise value of $2.85bn to reduce debt and streamline its business to three segments, including scents.

Beautycounter Founder Returns As CEO; Inter Parfum’s FY2023 Results; Cosmetics News

Gregg Renfrew will start as CEO at the company she founded on 1 February. Separately, International Flavors & Fragrances taps J. Erik Fyrwald to succeed Frank Clyburn as CEO, Inter Parfums reports fiscal 2023 full-year results, Yellow Wood Partners acquires Chapstick, and more.

IFF Sells Cosmetic Ingredients Biz To Clariant For $810M

Clariant believes it can grow International Flavors & Fragrances’ cosmetic ingredients business, principally Lucas Meyer active ingredients, functional ingredients and delivery systems, from $100m in sales annually to $180m by 2028. IFF will use proceeds from that and other recent divestures to pay down debt.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS154441

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel